title: Variable effects of soman on macromolecular secretion by ferret trachea.
abstract: The purpose of this study was to examine the effect of the anticholinesterase agent, soman, on macromolecular secretion by ferret trachea, in vitro. We mounted pieces of ferret trachea in Ussing-type chambers. Secreted sulfated macromolecules were radiolabeled by adding 500 microCi of 35SO4 to the submucosal medium and incubating for 17 hr. Soman added to the submucosal side produced a concentration-dependent increase in radiolabeled macromolecular release with a maximal secretory response (mean +/- SD) of 202 +/- 125% (n = 8) relative to the basal secretion rate at a concentration of 10(-7) M. The addition of either 10(-6) M pralidoxime (acetylcholinesterase reactivator) or 10(-6) M atropine blocked the response to 10(-7) M soman. At soman concentrations greater than 10(-7) M, secretion rate decreased and was not significantly different from basal secretion. Additional experiments utilizing acetylcholine and the acetylcholinesterase inhibitor, physostigmine, suggest that inhibition of secretion by high concentrations of soman may be due to a secondary antagonistic effect of soman on muscarinic receptors.
authors.affiliation: Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642.
authors.forename: R K
authors.initials: RK
authors.lastname: McBride
authors.forename: D J
authors.initials: DJ
authors.lastname: Zwierzynski
authors.forename: K K
authors.initials: KK
authors.lastname: Stone
authors.forename: D J
authors.initials: DJ
authors.lastname: Culp
authors.forename: M G
authors.initials: MG
authors.lastname: Marin
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002801:Cholinesterase Reactivators / Q000494:pharmacology; D005289:Ferrets; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D009924:Organ Culture Techniques; D011220:Pralidoxime Compounds / Q000494:pharmacology; D012999:Soman / Q000037:antagonists & inhibitors / Q000633:toxicity*; D013431:Sulfates / Q000378:metabolism; D013462:Sulfur Radioisotopes; D014132:Trachea / Q000187:drug effects / Q000378:metabolism*
chemical_list: D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; D013431:Sulfates; D013462:Sulfur Radioisotopes; D001285:Atropine; D012999:Soman; D007770:L-Lactate Dehydrogenase; D000109:Acetylcholine; C028797:pralidoxime